Article Details
Retrieved on: 2024-07-19 14:54:09
Tags for this article:
Click the tags to see associated articles and topics
Summary
The article discusses a study on early DOAC treatment for ischemic stroke and AF, highlighting its safety across different stroke severities. It aligns with 'Biotech' through the use of advanced pharmaceuticals for managing atrial fibrillation and associated conditions. Tags specify relevant medical aspects and scoring systems.
Article found on: www.thecardiologyadvisor.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here